SUSAN HANSON: Open Payments
NPI 1790190445 · MILFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 8 payments from 6 companies in 2025. Trend: 2023 $104 · 2024 $94 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $95 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Novo Nordisk Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: REXULTI, AIRSUPRA, BREZTRI, Ozempic, CAPLYTA, ZENPEP, MOUNJARO.
Industry payments across IL — which companies pay providers there.
